Loading...
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Due to compromised homologous recombination (HR) repair, BRCA1‐ and BRCA2‐mutated tumours accumulate DNA damage and genomic rearrangements conducive of tumour progression. To identify drugs that target specifically BRCA2‐deficient cells, we screened a chemical library containing compounds in clinica...
Na minha lista:
| Udgivet i: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609913/ https://ncbi.nlm.nih.gov/pubmed/31273933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201809982 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|